The cerebroprotection and prospects of FNDC5/irisin in stroke
2024 · Neuropharmacology · 9 citations
https://doi.org/10.1016/j.neuropharm.2024.109986
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
7
Papers
52
Citations
4
h-index
2
i10-index
Lingxiao Qi is an academic researcher from Second Affiliated Hospital of Zhengzhou University. The author has contributed to research in topics: Intracerebral and Subarachnoid Hemorrhage Research & Neuroinflammation and Neurodegeneration Mechanisms & Nanoparticle-Based Drug Delivery. The author has an h-index of 4, co-authored 6 publications.
https://doi.org/10.1016/j.neuropharm.2024.109986
https://doi.org/10.2147/jir.s515256
Click to start Chat